Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ramiro

Showing results (261-270 of 287) with videos related to

Pageof 29
Sort By:
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
RMD Open|June 5, 2018
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working GroupStavros Chrysidis, Christina Duftner, Christian Dejaco, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Instrument selection for the ASAS core outcome set for axial spondyloarthritisVictoria Navarro-Compán, Anne Boel, Annelies Boonen, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Pageof 29

Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
RMD Open|June 5, 2018
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working GroupStavros Chrysidis, Christina Duftner, Christian Dejaco, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|June 9, 2022
Instrument selection for the ASAS core outcome set for axial spondyloarthritisVictoria Navarro-Compán, Anne Boel, Annelies Boonen, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Pageof 29